Primary Care Diagnostics

06/15/2026

Peripheral arterial disease is not always easy to identify early, especially when symptoms are vague or inconsistent. This short video highlights how the TM Flow System helps support earlier PAD detection through objective in-office vascular testing, giving clinicians another tool to strengthen evaluation in at-risk patients.

06/08/2026

Dementia evaluation often involves more than memory loss alone. In our latest blog, we explore how the COGNISION® System adds objective ERP and EEG data to the dementia evaluation process, helping strengthen assessment when symptoms are subtle or difficult to define. By combining physiologic brain-function data with clinical judgment, providers can support more informed follow-up and stronger longitudinal care. Read the full blog here:

Dementia evaluation often requires more than observation Dementia is rarely evaluated on the basis of one symptom or one visit alone. Patients may present with memory concerns, slowed thinking, reduced attention, or subtle changes in day-to-day function that are difficult to define clearly during a....

06/01/2026

Peripheral arterial disease often develops gradually and may not become obvious until symptoms are more advanced. In our latest blog, we look at how the TM Flow System supports earlier detection of peripheral arterial disease by adding objective vascular data to the office visit. For patients with diabetes, hypertension, and other cardiometabolic risk factors, this added insight can help strengthen evaluation and support earlier intervention. Read the full blog here:

Why earlier PAD detection matters Peripheral arterial disease often develops gradually and may remain unrecognized until symptoms become more severe. Some patients present with classic exertional leg pain, but many do not. In clinical practice, reduced circulation may be overlooked when patients des...

05/22/2026

In patients with cardiometabolic disease, circulatory decline often begins before overt symptoms appear. The TM Flow System provides clinicians with a practical in-office method to identify these early changes and incorporate objective vascular data into ongoing care.

By detecting reduced perfusion earlier and supporting longitudinal monitoring, the TM Flow System helps strengthen chronic disease management, improve clinical decision-making, and support better long-term outcomes in at-risk patients.

05/15/2026

One of the challenges in dementia evaluation is that early symptoms are often easy to dismiss or difficult to define. A patient may seem mostly functional yet still show subtle decline. A family member may report concerning changes that are not obvious during the visit. In these situations, objective testing can provide valuable support.

The COGNISION® System helps strengthen evaluation by adding measurable brain-function data to the overall assessment. This can help clinicians determine whether closer follow-up, additional workup, or referral is warranted.

05/08/2026

Traditional cardiometabolic monitoring remains essential, but numbers such as A1c, blood pressure, and lipid panels do not always show how disease is affecting tissue perfusion in real time. A patient may appear relatively stable on paper while vascular changes continue to progress.

The TM Flow System helps bridge that gap by providing physiologic information that reflects how circulation is functioning at the point of care. This can support earlier recognition of patients who may need closer follow-up, more aggressive risk reduction, or additional vascular evaluation.

Why early circulatory changes are often missed Cardiometabolic disease rarely begins with a major clinical event. More often, vascular changes develop gradually over time as diabetes, hypertension, obesity, and metabolic syndrome begin to affect circulation long before a patient presents with advanc...

05/01/2026

The COGNISION® System provides in-office ERP and EEG testing designed to support cognitive evaluation through objective physiologic measurement. During testing, patients wear a headset while brain responses to auditory stimuli are recorded. These responses offer insight into neural processing associated with attention and working memory, while resting EEG adds information about background brain activity.

Dementia evaluation is rarely straightforward Evaluating dementia in clinical practice often involves more than identifying memory loss alone. Early cognitive decline may present as slowed thinking, reduced attention, difficulty with working memory, or subtle changes in day-to-day functioning that a...

04/21/2026

Early cognitive decline can be difficult to detect when symptoms are mild or inconsistent. This short video explains how the COGNISION® System helps establish cognitive baselines through in-office ERP and EEG testing, giving providers objective data to support monitoring and earlier dementia detection over time.

04/14/2026

How do you track cardiometabolic risk beyond symptoms and routine lab work? This short video highlights how the TM Flow System provides objective in-office data to support long-term monitoring of vascular and nerve-related changes. It is a practical look at how trending physiologic data can strengthen chronic disease management and help guide earlier intervention.

04/07/2026

Establishing a cognitive baseline can make a meaningful difference when patients begin showing subtle signs of memory or processing changes. In our latest blog, we explore how the COGNISION® System supports baseline brain function testing in patients at risk for dementia through objective ERP and EEG data. These measurements can help clinicians track change over time and support earlier, more confident decision-making. Read the full blog here:

Why Cognitive Baselines Matter Cognitive decline often begins gradually, with subtle changes that may be difficult to detect during routine clinical visits. Patients may report occasional forgetfulness or slowed thinking, but early symptoms can overlap with normal aging or temporary stress. Without....